Table 1.
Patient | Sex | Age | Cancer Diagnosis | Histologic Classification | Cancer Stage | Method of COVID-19 Diagnosis |
---|---|---|---|---|---|---|
1 (Kirakli et al.12) | M | 61 | Lung | AC | T4N2M1 | PCR |
2 | M | 72 | Lung | SCC | T4N2M0 | NPS |
3 | M | 65 | Lung | SCC | T4N0M0 | PCR |
4 | F | 74 | Lung | AC | T3N2M0 | PCR |
5 | M | 66 | Lung | AC | TxN3M0 | NPS |
6 | F | 63 | Lung | SCC | T4N0M0 | PCR |
7 | F | 77 | Lung | SCC | T1cN2M0 | NPS |
8 (Suppli et al.9) | M | 74 | Lung | AC | T3N2M0 | PCR |
9 (McGinnis et al.10) | F | 63 | Lung | AC | Recurrent | PCR |
AC, adenocarcinoma; COVID-19, coronavirus disease 2019; F, female; M, male; NPS, nasopharyngeal swab; PCR, polymerase chain reaction; SCC, squamous cell carcinoma.